tirzepatide side effects bad breath Effects: Common & Rare Reactions Explained Tirzepatide Side Effects: Timeline, Symptoms,

Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)

122 High-risk patients, such as those with multiple predisposing factors like T2DM, MASLD, rapid weight loss, and previous gallbladder disease, need more intensive treatment strategies, including periodic biochemical and imaging follow-up, and consideration of prophylactic treatment with ursodeoxycholic acid to prevent gallstone formation

Repeated or prolonged warm exposure degrades the peptide significantly

If youre wondering what makes semaglutide different, it all comes down to GLP-1

Tirzepatide is noted for its efficacy when compared to other GLP-1 receptor agonists

doi:10.1126/scitranslmed.3007218 16